23 January 2017
News and Views
Links and Services
A study published in July's issue of the Alimentary Pharmacology & Therapeutics reports on the clinical outcomes and healthcare resource utilization of infliximab treatment in Crohn's disease.
Crohn's disease places a substantial burden on healthcare systems, with the majority of costs ari
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors